Asia Pacific Transient Protein Expression Market Forecast to 2031 - Regional Analysis - by Product Type, Application, and End User

Description

List of Tables

The Asia Pacific transient protein expression market was valued at US$ 181.05 million in 2023 and is expected to reach US$ 294.26 million by 2031; it is estimated to register a CAGR of 6.3% from 2023 to 2031.

Plant-Based Expression Systems for Therapeutic Protein Production Boost Asia Pacific Transient Protein Expression Market

The use of microbial or mammalian cell-based expression systems has been a common practice in recombinant protein production processes; however, plant-based expression has been promoted as a cost-effective, scalable, safe, and sustainable alternative in recent years. The duration of protein synthesis has been greatly shortened and the yield of recombinant proteins in plants has improved thanks to the creation and advancement of transient expression methods. A shift in consumer preference toward plant-based products compels pharmaceutical and biopharmaceutical companies to focus on plant-based synthesis of therapeutic proteins. The use of plants has excellent potential for improving yields of proteins that can be administered for the prevention or treatment of human and animal diseases. The use of therapeutic proteins is likely to surge in the healthcare sector in the coming years due to the ongoing restructuring of regulatory frameworks and growing awareness about transient protein expression in plants. Maximum scale-up possibility, low growth costs, complex protein production ability, low contamination (especially involving human pathogens) risks, and optimized growth conditions are among the key advantages associated with transient protein expression in plants. Moreover, plants are considered safer compared to other expression systems as they do not produce endotoxins and cause less harm to humans. Thus, plant-based expression systems for therapeutic protein expression are emerging as vital opportunities for the transient protein expression market growth during the forecast period.

Asia Pacific Transient Protein Expression Market Overview

The transient protein expression market in Asia Pacific is sub segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. The market growth in this region is attributed to growing biotechnology industry across several countries in Asia Pacific, increasing software product launches, and increasing developments and improvements in transient protein expression systems.

Asia Pacific Transient Protein Expression Market Revenue and Forecast to 2031 (US$ Million)

Asia Pacific Transient Protein Expression Market Segmentation

The Asia Pacific transient protein expression market is categorized into product type, application, end user, and country.

Based on product type, the Asia Pacific transient protein expression market is segmented into instruments, reagents, expression vectors, and competent cells. The instruments segment held the largest market share in 2023.

In terms of application, the Asia Pacific transient protein expression market is segmented into genomic research, gene therapy, bio production, cancer research, and drug development. The genomic research segment held the largest market share in 2023.

Based on end user, the Asia Pacific transient protein expression market is segmented into pharmaceutical and biotechnology companies, academic and research institutes, and clinical research organizations. The pharmaceutical and biotechnology companies segment held the largest market share in 2023.

By country, the Asia Pacific transient protein expression market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific transient protein expression market share in 2023.

Thermo Fisher Scientific Inc, Merck KGaA, QIAGEN NV, GenScript Biotech Corporation, Promega Corp, Takara Bio Inc, New England Biolabs, Agilent Technologies Inc, Mirus Bio LLC, Bio-Rad Laboratories Inc, Lonza Group AG, and MaxCyte Inc are some of the leading companies operating in the Asia Pacific transient protein expression market.

Product Code: TIPRE00022176

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. Asia Pacific Transient Protein Expression Market - Key Market Dynamics

4.1 Market Drivers
- 4.1.1 Increasing Applications of Protein Expression Systems
- 4.1.2 Surging Popularity of Precision Medicine
4.2 Market Restraints
- 4.2.1 High Cost of Products
4.3 Market Opportunities
- 4.3.1 Plant-Based Expression Systems for Therapeutic Protein Production
4.4 Future Trends
- 4.4.1 Integration of Artificial Intelligence (AI) and Automation Technologies
4.5 Impact of Drivers and Restraints:

5. Transient Protein Expression Market - Asia Pacific Analysis

5.1 Asia Pacific Transient Protein Expression Market Revenue (US$ Million), 2021-2031
5.2 Asia Pacific Transient Protein Expression Market Forecast Analysis

6. Asia Pacific Transient Protein Expression Market Analysis - by Product Type

6.1 Instruments
- 6.1.1 Overview
- 6.1.2 Instruments: Asia Pacific Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)
6.2 Reagents
- 6.2.1 Overview
- 6.2.2 Reagents: Asia Pacific Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)
6.3 Expression Vectors
- 6.3.1 Overview
- 6.3.2 Expression Vectors: Asia Pacific Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)
6.4 Competent Cells
- 6.4.1 Overview
- 6.4.2 Competent Cells: Asia Pacific Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)

7. Asia Pacific Transient Protein Expression Market Analysis - by Application

7.1 Genomic Research
- 7.1.1 Overview
- 7.1.2 Genomic Research: Asia Pacific Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)
7.2 Gene Therapy
- 7.2.1 Overview
- 7.2.2 Gene Therapy: Asia Pacific Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Bio production
- 7.3.1 Overview
- 7.3.2 Bio production: Asia Pacific Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)
7.4 Cancer Research
- 7.4.1 Overview
- 7.4.2 Cancer Research: Asia Pacific Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)
7.5 Drug Development
- 7.5.1 Overview
- 7.5.2 Drug Development: Asia Pacific Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)

8. Asia Pacific Transient Protein Expression Market Analysis - by End User

8.1 Pharmaceutical and Biotechnology Companies
- 8.1.1 Overview
- 8.1.2 Pharmaceutical and Biotechnology Companies: Asia Pacific Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)
8.2 Academic and Research Institutes
- 8.2.1 Overview
- 8.2.2 Academic and Research Institutes: Asia Pacific Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Clinical Research Organizations
- 8.3.1 Overview
- 8.3.2 Clinical Research Organizations: Asia Pacific Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)

9. Asia Pacific Transient Protein Expression Market - Country Analysis

9.1 Asia Pacific
- 9.1.1 Asia Pacific Transient Protein Expression Market Overview
- 9.1.2 Asia Pacific: Transient Protein Expression Market - Revenue and Forecast Analysis - by Country
  - 9.1.2.1 Asia Pacific: Transient Protein Expression Market - Revenue and Forecast Analysis - by Country
  - 9.1.2.2 China: Asia Pacific Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)
    - 9.1.2.2.1 China: Asia Pacific Transient Protein Expression Market Breakdown, by Product Type
    - 9.1.2.2.2 China: Asia Pacific Transient Protein Expression Market Breakdown, by Application
    - 9.1.2.2.3 China: Asia Pacific Transient Protein Expression Market Breakdown, by End User
  - 9.1.2.3 Japan: Asia Pacific Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)
    - 9.1.2.3.1 Japan: Asia Pacific Transient Protein Expression Market Breakdown, by Product Type
    - 9.1.2.3.2 Japan: Asia Pacific Transient Protein Expression Market Breakdown, by Application
    - 9.1.2.3.3 Japan: Asia Pacific Transient Protein Expression Market Breakdown, by End User
  - 9.1.2.4 India: Asia Pacific Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)
    - 9.1.2.4.1 India: Asia Pacific Transient Protein Expression Market Breakdown, by Product Type
    - 9.1.2.4.2 India: Asia Pacific Transient Protein Expression Market Breakdown, by Application
    - 9.1.2.4.3 India: Asia Pacific Transient Protein Expression Market Breakdown, by End User
  - 9.1.2.5 Australia: Asia Pacific Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)
    - 9.1.2.5.1 Australia: Asia Pacific Transient Protein Expression Market Breakdown, by Product Type
    - 9.1.2.5.2 Australia: Asia Pacific Transient Protein Expression Market Breakdown, by Application
    - 9.1.2.5.3 Australia: Asia Pacific Transient Protein Expression Market Breakdown, by End User
  - 9.1.2.6 South Korea: Asia Pacific Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)
    - 9.1.2.6.1 South Korea: Asia Pacific Transient Protein Expression Market Breakdown, by Product Type
    - 9.1.2.6.2 South Korea: Asia Pacific Transient Protein Expression Market Breakdown, by Application
    - 9.1.2.6.3 South Korea: Asia Pacific Transient Protein Expression Market Breakdown, by End User
  - 9.1.2.7 Rest of Asia Pacific: Asia Pacific Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)
    - 9.1.2.7.1 Rest of Asia Pacific: Asia Pacific Transient Protein Expression Market Breakdown, by Product Type
    - 9.1.2.7.2 Rest of Asia Pacific: Asia Pacific Transient Protein Expression Market Breakdown, by Application
    - 9.1.2.7.3 Rest of Asia Pacific: Asia Pacific Transient Protein Expression Market Breakdown, by End User

10. Competitive Landscape

10.1 Company Positioning & Concentration

11. Industry Landscape

11.1 Overview
11.2 Growth Strategies in Asia Pacific Transient Protein Expression Market
11.3 Organic Growth Strategies
- 11.3.1 Overview
11.4 Inorganic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 Thermo Fisher Scientific Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Merck KGaA
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 QIAGEN NV
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 GenScript Biotech Corporation
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Promega Corp
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Takara Bio Inc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 New England Biolabs
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Agilent Technologies Inc
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Mirus Bio LLC
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Bio-Rad Laboratories Inc
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
12.11 Lonza Group AG
- 12.11.1 Key Facts
- 12.11.2 Business Description
- 12.11.3 Products and Services
- 12.11.4 Financial Overview
- 12.11.5 SWOT Analysis
- 12.11.6 Key Developments
12.12 MaxCyte Inc
- 12.12.1 Key Facts
- 12.12.2 Business Description
- 12.12.3 Products and Services
- 12.12.4 Financial Overview
- 12.12.5 SWOT Analysis
- 12.12.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms